pimonidazole
Showing 1 - 25 of 29
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)
Recruiting
- Prostate Cancer
- Hypoxia
- Optional non-IMP pimonidazole
- +8 more
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Jan 26, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- fMRI
- Oral Pimonidazole
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Center
Oct 9, 2023
Aortic Aneurysm, Thoracic Trial in Baltimore (Pimonidazole HCl)
Recruiting
- Aortic Aneurysm, Thoracic
- Pimonidazole hydrochloride
-
Baltimore, MarylandUniversity of Maryland, Baltimore
Aug 5, 2021
Tongue Cancer Trial in Toronto ((18)F-Fluoroazomycin arabinoside, Pimonidazole)
Recruiting
- Tongue Cancer
- (18)F-Fluoroazomycin arabinoside
- Pimonidazole
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 20, 2021
Sarcoma Trial in Toronto (18F-FAZA, Pimonidazole)
Recruiting
- Sarcoma
- 18F-FAZA
- Pimonidazole
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 11, 2022
Metabolic and Immune Dysfunction in In-transit Melanoma
Recruiting
- Melanoma
- Pimonidazole
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 11, 2022
Prostate Cancer Trial in Toronto (Pimonidazole)
Active, not recruiting
- Prostate Cancer
- Pimonidazole
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 4, 2021
Pancreatic Cancer, Resectable Pancreatic Cancer Trial in Tampa (Pimonidazole, Surgical Resection)
Withdrawn
- Pancreatic Cancer
- Resectable Pancreatic Cancer
- Pimonidazole
- Surgical Resection
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Feb 3, 2021
Hypoxia and the Immune Environment in Myeloma Patients (CHIME)
Not yet recruiting
- Myeloma
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Aug 16, 2023
Cancer Trial in Sutton (Hypoxia marker)
Completed
- Cancer
- Hypoxia marker
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Dec 20, 2019
Prostate Cancer, Physical Activity, Hypoxia Trial in Tromsø (Physical activity)
Terminated
- Prostate Cancer
- +2 more
- Physical activity
-
Tromsø, NorwayUniversity Hospital of North Norway
Jan 5, 2023
Role of Nox2 in CNI-induced Renal Fibrosis
Completed
- Kidney Disease
- Hypoxyprobe-1
-
Madison, Wisconsin
- +1 more
Oct 10, 2019
Hypoxia-Induced Prostate Cancer Aggressiveness
Active, not recruiting
- Prostatic Neoplasms
- +2 more
-
Oslo, NorwayOslo University Hospital
Jun 16, 2022
Intratumoral Hypoxia Using Pre-operative Administration of
Completed
- Pancreatic Cancer
- Pimonidazole hydrochloride
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 27, 2018
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or
Terminated
- Ovarian Cancer
- Ovarian Neoplasms
- 18F-EF5 PET/CT scan
- Optional biopsy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Feb 2, 2022
Colon Rectal Cancer Adenocarcinoma Trial in Toronto
Completed
- Colon Rectal Cancer Adenocarcinoma
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Aug 15, 2019
Prostate Cancer Trial in Copenhagen (High Intensity Interval Training bout)
Completed
- Prostate Cancer
- High Intensity Interval Training bout
-
Copenhagen, DenmarkCenter for Physical Activity Research, Copenhagen University Hos
Dec 12, 2019
Refractory Pulmonary Tuberculosis Trial in Masan (Pimonidazole HCl)
Withdrawn
- Refractory Pulmonary Tuberculosis
- Pimonidazole hydrochloride
-
Masan, Korea, Republic of
- +1 more
Jun 30, 2017
NSCLC Trial in Oxford (Atovaquone)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Sep 2, 2019
Prostate Cancer Trial in Toronto (Fluvastatin, Pimonidazole)
Completed
- Prostate Cancer
- Fluvastatin
- Pimonidazole
-
Toronto, Ontario, CanadaUniversity Health Network- The Princess Margaret Cancer Centre
Oct 24, 2017
Hypoxia in Rectal Cancer Trial in Oxford (Pimonidazole, F-MISO PET, pCT)
Completed
- Hypoxia in Rectal Cancer
- Pimonidazole
- +5 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Mar 8, 2017
Melanoma, Skin Cancer Trial (Pimonidazole HCl (Hypoxyprobe™-1), Optional 18F-FMISO PET scan (18F-fluoromisonidazole), Surgical
Withdrawn
- Melanoma
- Skin Cancer
- Pimonidazole hydrochloride (Hypoxyprobe™-1)
- +2 more
- (no location specified)
May 6, 2016
Head Neck Cancer Trial in London (PET/CT)
Completed
- Head and Neck Cancer
- PET/CT
-
London, Ontario, CanadaLondon Health Science Center
Aug 25, 2017
Head Neck Cancer Trial in Zürich (Pimonidazole)
Unknown status
- Head and Neck Cancer
- Pimonidazole
-
Zürich, SwitzerlandDepartment of Cranio-, Maxillofacial and Oral Surgery
Jun 16, 2016